MEDINCELL SA (MEDCL.PA) Stock Analyst Ratings

Europe • Euronext Paris • EPA:MEDCL • FR0004065605

23.18 EUR
+0.62 (+2.75%)
Last: Feb 2, 2026, 07:00 PM
Buy % Consensus

86

ChartMill assigns a Buy % Consensus number of 86% to MEDCL.PA. The Buy consensus is the weighted average rating of the current analysts ratings.

  • Analysts have set a mean price target forecast of 35.99. This target is 55.28% above the current price.
  • MEDCL.PA was analyzed by 17 analysts. The buy percentage consensus is at 86. So analysts seem to be very confident about MEDCL.PA.
  • In the previous month the buy percentage consensus was at a similar level.
  • MEDCL.PA was analyzed by 17 analysts, which is quite many. So the average rating should be quite meaningful.

Related screens

MEDCL.PA Historical Analyst RatingsMEDCL.PA Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -85 -77 -69 -61 -53 -45 -37 -29 -21 -13 -5 5 10 15

Price Target & Forecast

Price Low Median Mean High 23.1827.2734.5335.9952.50 - 17.64% 48.95% 55.28% 126.49%

Related screens

MEDCL.PA Current Analyst RatingMEDCL.PA Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6 8
Up and Down Grades
Date Firm Action Rating
2026-01-26 PORTZAMPARC BNP PARIBAS Maintains Buy -> Buy
2023-08-30 MIDCAP PARTNERS Maintains Buy -> Buy

MEDINCELL SA / MEDCL.PA FAQ

What is the average price target for MEDINCELL SA (MEDCL.PA) stock?

17 analysts have analysed MEDCL.PA and the average price target is 35.99 EUR. This implies a price increase of 55.28% is expected in the next year compared to the current price of 23.18.


How do analysts rate MEDINCELL SA (MEDCL.PA)?

The consensus rating for MEDINCELL SA (MEDCL.PA) is 85.8824 / 100 . This indicates that analysts generally have a positive outlook on the stock.